Access

Article


Nature Medicine 12, 636 - 641 (2006)
Published online: 4 June 2006 | doi:10.1038/nm1407

The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection

Milan Chromek1, Zuzana Slamová1, Peter Bergman2, László Kovács3, L'udmila Podracká4, Ingrid Ehrén5, Tomas Hökfelt6, Gudmundur H Gudmundsson7, Richard L Gallo8, Birgitta Agerberth2 & Annelie Brauner1


The urinary tract functions in close proximity to the outside environment, yet must remain free of microbial colonization to avoid disease. The mechanisms for establishing an antimicrobial barrier in this area are not completely understood. Here, we describe the production and function of the cathelicidin antimicrobial peptides LL-37, its precursor hCAP-18 and its ortholog CRAMP in epithelial cells of human and mouse urinary tract, respectively. Bacterial contact with epithelial cells resulted in rapid production and secretion of the respective peptides, and in humans LL-37/hCAP-18 was released into urine. Epithelium-derived cathelicidin substantially contributed to the protection of the urinary tract against infection, as shown using CRAMP-deficient and neutrophil-depleted mice. In addition, clinical E. coli strains that were more resistant to LL-37 caused more severe urinary tract infections than did susceptible strains. Thus, cathelicidin seems to be a key factor in mucosal immunity of the urinary tract.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Shigellae control the Gates of LL

Nature Medicine News and Views (01 Feb 2001)

An important clue: fingerprints point to psoriasin in defense against E. coli

Nature Immunology News and Views (01 Jan 2005)

See all 4 matches for News And Views